Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sanofi (SNY) Amortization - Intangibles (2016 - 2025)

Sanofi's Amortization - Intangibles history spans 15 years, with the latest figure at $4.4 billion for Q4 2025.

  • On a quarterly basis, Amortization - Intangibles rose 25.56% to $4.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 0.73% increase, with the full-year FY2025 number at $2.1 billion, up 10.61% from a year prior.
  • Amortization - Intangibles hit $4.4 billion in Q4 2025 for Sanofi, up from -$1.4 billion in the prior quarter.
  • Over the last five years, Amortization - Intangibles for SNY hit a ceiling of $4.4 billion in Q4 2025 and a floor of -$1.7 billion in Q2 2023.
  • Historically, Amortization - Intangibles has averaged $249.2 million across 5 years, with a median of -$434.1 million in 2025.
  • The widest YoY moves for Amortization - Intangibles: up 540.99% in 2023, down 237.36% in 2023.
  • Tracing SNY's Amortization - Intangibles over 5 years: stood at $480.5 million in 2021, then crashed by 197.04% to -$466.3 million in 2022, then surged by 540.99% to $2.1 billion in 2023, then skyrocketed by 70.93% to $3.5 billion in 2024, then grew by 25.56% to $4.4 billion in 2025.
  • Business Quant data shows Amortization - Intangibles for SNY at $4.4 billion in Q4 2025, -$1.4 billion in Q3 2025, and -$427.9 million in Q2 2025.